SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-004107
Filing Date
2013-08-14
Accepted
2013-08-14 06:15:10
Documents
14
Period of Report
2013-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50690734.htm 8-K 19299
2 EXHIBIT 99.1 a50690734ex99_1.htm EX-99.1 58221
3 EXHIBIT 99.2 a50690734ex99_2.htm EX-99.2 18024
4 SLIDE 1 slide1.jpg GRAPHIC 248059
5 SLIDE 2 slide2.jpg GRAPHIC 481488
6 SLIDE 3 slide3.jpg GRAPHIC 197621
7 SLIDE 4 slide4.jpg GRAPHIC 166087
8 SLIDE 5 slide5.jpg GRAPHIC 284258
9 SLIDE 6 slide6.jpg GRAPHIC 292492
10 SLIDE 7 slide7.jpg GRAPHIC 305777
11 SLIDE 8 slide8.jpg GRAPHIC 222016
12 SLIDE 9 slide9.jpg GRAPHIC 280802
13 SLIDE 10 slide10.jpg GRAPHIC 212251
14 SLIDE 11 slide11.jpg GRAPHIC 249070
  Complete submission text file 0001157523-13-004107.txt   4149072
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 131034852
SIC: 2834 Pharmaceutical Preparations